Wells Fargo’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.68M Buy
+4,000
New +$4.06M ﹤0.01% 2837
2025
Q4
Sell
-15,000
Closed -$11.4M 7259
2025
Q3
$11.4M Buy
+15,000
New +$11.2M ﹤0.01% 1890
2025
Q2
Sell
-172,300
Closed -$142M 7274
2025
Q1
$142M Buy
172,300
+157,100
+1,034% +$131M 0.03% 403
2024
Q4
$11.7M Sell
15,200
-30,000
-66% -$24.8M ﹤0.01% 1735
2024
Q3
$40M Buy
+45,200
New +$40.6M 0.01% 904
2024
Q1
Sell
-800
Closed -$466K 7626
2023
Q4
$466K Hold
800
﹤0.01% 3920
2023
Q3
$430K Hold
800
﹤0.01% 3876
2023
Q2
$375K Sell
800
-3,100
-79% -$1.3M ﹤0.01% 4153
2023
Q1
$1.34M Buy
3,900
+3,300
+550% +$1.11M ﹤0.01% 3170
2022
Q4
$220K Sell
600
-19,400
-97% -$6.88M ﹤0.01% 4126
2022
Q3
$6.47M Buy
+20,000
New +$6.34M ﹤0.01% 1816
2022
Q1
Sell
-615,400
Closed -$170M 7490
2021
Q4
$170M Buy
615,400
+513,000
+501% +$130M 0.04% 326
2021
Q3
$23.7M Buy
102,400
+77,400
+310% +$19.1M 0.01% 1535
2021
Q2
$5.74M Buy
+25,000
New +$5.02M ﹤0.01% 2738
2017
Q4
Sell
-14,400
Closed -$73K 6448
2017
Q3
$73K Buy
+14,400
New +$1.18M ﹤0.01% 5344

Other funds holding LLY

Wells Fargo's LLY Position: Q1 2026 in Review

Wells Fargo increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $74.2M and bringing the position to 4,405,844 shares worth $4.05B. The position accounts for 0.76% of the portfolio, ranked #19.

Wells Fargo first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.66B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Wells Fargo held 4,405,844 shares of Eli Lilly worth $4.05B as of Q1 2026.
  • Wells Fargo bought 73,189 Eli Lilly shares in Q1 2026, an estimated $74.2M.
  • Eli Lilly made up 0.76% of Wells Fargo's portfolio in Q1 2026, its #19 holding.
  • Wells Fargo first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Eli Lilly position peaked at $4.66B in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.